May 17, 2018

APS and screening: 2012 guidelines updated in the US

The US Preventive Services Task Force is now recommending increased screening for prostate cancer, a move that reverses previous guidelines that recommended against routine prostate cancer screening.

This week, the US Task Force updated its 2012 position on prostate cancer screening recommending that clinicians should selectively offer or provide periodic prostate-specific antigen (PSA)–based screening for prostate cancer for men between the ages of 55 to 69. The working group maintained its recommendation against PSA-based screening for prostate cancer in men 70 years and older.

Published in the Journal of the American Medical Association, the group concluded that the decision to undergo routine PSA-based screening in men aged 55 to 69 should be an individual one that includes a discussion of the potential benefits and harms of screening.

While the recommendations of this group are a step in the right direction, the Prostate Cancer Foundation (PCF), one of the world's leading philanthropic organizations that funds and accelerates prostate cancer research, responded by stating that anyone over the age of 50 should be able to talk to their doctor about whether prostate cancer screening is appropriate for them, especially black men and those with a history of cancer, who should address screening in their early forties.

Their position is also clear for men aged 70 and over, stating that an age-only recommendation may not be appropriate for all men over 70 and instead advocates a personalized approach that takes into account health, values and preferences.

Même son de cloche chez la, qui a indiqué lors d’une entrevue sur le sujet que les symptômes du cancer de la prostate peuvent être minimes ou inexistants jusqu'à ce que le cancer ne soit plus guérissable.

The same is true of the American Cancer Society, which said in an interview on the subject that symptoms of prostate cancer may be minimal or nonexistent until the cancer is no longer curable.

As for PROCURE's position, it remains the same: if you have a life expectancy of more than 10 years, you should consider prostate cancer screening from 50 years old in agreement with your doctor and from 40 years old if you have a cancer history or that you are of African descent. Do not hesitate to consult All about screening here.

Written by PROCURE. © All rights reserved - 2018

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Retour
PROCURE In the News